BioInvent International AB (publ) carries out private placement
BioInvent International AB (publ) announced on 1 June 2011 that the company, by virtue of the authorization by the annual general meeting on 24 March 2011, have completed a private placement of new shares through an accelerated bookbuilding procedure. The private placement provides the company with approximately SEK 136 million before transactions costs.
BioInvent was advised by Mannheimer Swartling in connection with the private placement. Madeleine Rydberger handled the assignment and was assisted by Nils Nostell and Jakob Wijkander.